Survival curves comparing patient groups with high and low TRA16 expression were generated for these cancers, with log-rank p-values of 0.0032 (LIHC), 6.6e-05 (LGG), and 0.01 (ACC), respectively, and confidence intervals were provided (Figure 1C). The gene discussed is NR2C2AP; the disease is cancer.